hydroxychloroquine has been researched along with Lipodystrophy in 5 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
Lipodystrophy: A collection of heterogenous conditions resulting from defective LIPID METABOLISM and characterized by ADIPOSE TISSUE atrophy. Often there is redistribution of body fat resulting in peripheral fat wasting and central adiposity. They include generalized, localized, congenital, and acquired lipodystrophy.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study aimed to investigate the relationship between centrifugal lipodystrophy (CLD) and lupus erythematosus panniculitis (LEP), and the efficacy and safety of hydroxychloroquine (HCQ) for treating CLD in children." | 8.12 | Centrifugal lipodystrophy on a spectrum with lupus erythematosus panniculitis in children and efficacy and safety of hydroxychloroquine: A clinicopathological study. ( Gu, Y; Li, Y; Ling, B; Lu, Z; Qiu, Y; Xu, Q; Yao, Z; Yu, H, 2022) |
| "This study aimed to investigate the relationship between centrifugal lipodystrophy (CLD) and lupus erythematosus panniculitis (LEP), and the efficacy and safety of hydroxychloroquine (HCQ) for treating CLD in children." | 4.12 | Centrifugal lipodystrophy on a spectrum with lupus erythematosus panniculitis in children and efficacy and safety of hydroxychloroquine: A clinicopathological study. ( Gu, Y; Li, Y; Ling, B; Lu, Z; Qiu, Y; Xu, Q; Yao, Z; Yu, H, 2022) |
| "Lipoatrophic panniculitis (LP) is a rare disease of childhood characterized by eruption of tender erythematous nodules and plaques followed by circumferential bands of lipoatrophy often seen on the arms and legs." | 1.36 | Lipoatrophic panniculitis: case report and review of the literature. ( Edmonson, MB; Gottam, CC; Hinshaw, MA; Shen, LY; Teng, JM; Williams, GP, 2010) |
| "Lipodystrophy was seen in 10/33 (30." | 1.33 | Twelve years experience of juvenile dermatomyositis in North India. ( Bansal, A; Singh, S, 2006) |
| "She was diagnosed as having lupus panniculitis." | 1.32 | Lupus panniculitis with combined features of dermatomyositis resulting in severe lipoatrophy. ( Cho, KH; Jo, SJ; Yoo, JY, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xu, Q | 1 |
| Qiu, Y | 1 |
| Lu, Z | 1 |
| Yu, H | 1 |
| Ling, B | 1 |
| Li, Y | 1 |
| Gu, Y | 1 |
| Yao, Z | 1 |
| Garnica-Cruz, P | 1 |
| Durán-Mckinster, C | 1 |
| Orozco-Covarrubias, ML | 1 |
| Saéz de Ocariz, MDM | 1 |
| Palacios-López, CG | 1 |
| García-Romero, MT | 1 |
| Shen, LY | 1 |
| Edmonson, MB | 1 |
| Williams, GP | 1 |
| Gottam, CC | 1 |
| Hinshaw, MA | 1 |
| Teng, JM | 1 |
| Yoo, JY | 1 |
| Jo, SJ | 1 |
| Cho, KH | 1 |
| Singh, S | 1 |
| Bansal, A | 1 |
5 other studies available for hydroxychloroquine and Lipodystrophy
| Article | Year |
|---|---|
Centrifugal lipodystrophy on a spectrum with lupus erythematosus panniculitis in children and efficacy and safety of hydroxychloroquine: A clinicopathological study.
Topics: Alopecia; Child; Female; Humans; Hydroxychloroquine; Infant; Lipodystrophy; Male; Panniculitis; Pann | 2022 |
Acquired localized lipoatrophy in children is frequently caused by preceding injections: a retrospective study of 12 patients.
Topics: Anti-Bacterial Agents; Biopsy; Child; Child, Preschool; Female; Follow-Up Studies; Glucocorticoids; | 2020 |
Lipoatrophic panniculitis: case report and review of the literature.
Topics: Ankle; Anti-Inflammatory Agents; Antirheumatic Agents; Biopsy; Child; Drug Therapy, Combination; Hum | 2010 |
Lupus panniculitis with combined features of dermatomyositis resulting in severe lipoatrophy.
Topics: Biopsy, Needle; Child; Dermatomyositis; Female; Follow-Up Studies; Humans; Hydroxychloroquine; Immun | 2004 |
Twelve years experience of juvenile dermatomyositis in North India.
Topics: Adolescent; Age of Onset; Azathioprine; Calcinosis; Child; Child, Preschool; Deglutition Disorders; | 2006 |